| Date Filed | Type | Description |
| 05/27/2022 |
4
| JOHNSON JAMES A (Director) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 13,871 options to buy
@ $8.93, valued at
$123.9k
|
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
3
| JOHNSON JAMES A (Director) has filed a Form 3 on Athira Pharma, Inc. |
| 09/05/2017 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 594 shares
@ $13.2, valued at
$7.8k
|
|
| 03/03/2017 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc |
| 02/08/2017 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc |
| 11/14/2016 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc |
| 09/06/2016 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc |
| 03/03/2016 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 760 shares
@ $9.52, valued at
$7.2k
|
|
| 02/05/2016 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 10,000 options to buy
@ $0
Granted 20,000 options to buy
@ $12.94, valued at
$258.8k
|
|
| 09/03/2015 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 761 shares
@ $9.52, valued at
$7.2k
|
|
| 03/04/2015 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 789 shares
@ $9.52, valued at
$7.5k
|
|
| 02/11/2015 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 45,000 options to buy
@ $12.77, valued at
$574.7k
|
|
| 09/04/2014 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 1,063 shares
@ $6.6215, valued at
$7k
|
|
| 03/05/2014 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 1,096 shares
@ $6.6215, valued at
$7.3k
|
|
| 02/04/2014 |
4
| JOHNSON JAMES A (CFO) has filed a Form 4 on NanoString Technologies Inc|
Txns:
| Granted 45,000 options to buy
@ $18.18, valued at
$818.1k
|
|
| 06/25/2013 |
3
| JOHNSON JAMES A (CFO) has filed a Form 3 on NanoString Technologies Inc |
| 10/12/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2009 |
4
| JOHNSON JAMES A (Executive VP and CFO) has filed a Form 4 on ZYMOGENETICS INC|
Txns:
| Granted 13,385 options to buy
@ $6.35, valued at
$85k
Granted 20,877 options to buy
@ $6.35, valued at
$132.6k
Granted 17,865 options to buy
@ $6.35, valued at
$113.4k
Granted 29,828 options to buy
@ $6.35, valued at
$189.4k
Granted 13,028 options to buy
@ $6.35, valued at
$82.7k
Disposed/sold 22,800 options to buy
@ $14.73, valued at
$335.8k
Disposed/sold 52,200 options to buy
@ $15.27, valued at
$797.1k
Disposed/sold 44,665 options to buy
@ $18.38, valued at
$820.9k
Disposed/sold 52,194 options to buy
@ $21.26, valued at
$1.1M
Disposed/sold 33,465 options to buy
@ $17.15, valued at
$573.9k
|
|
| 12/08/2009 |
4
| JOHNSON JAMES A (Executive VP and CFO) has filed a Form 4 on ZYMOGENETICS INC|
Txns:
| Sold 10,000 shares
@ $7, valued at
$70k
Exercised 10,000 options to buy
@ $2.7777, valued at
$27.8k
|
|
| 09/02/2009 |
4
| JOHNSON JAMES A (Executive VP and CFO) has filed a Form 4 on ZYMOGENETICS INC |
| 05/19/2009 |
4
| JOHNSON JAMES A (Executive VP and CFO) has filed a Form 4 on ZYMOGENETICS INC |
| 01/31/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |